Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v3-EN | Version v1-EN | |
|---|---|---|
| Language | English | English |
| Date Updated | 2020-11-03 | 2020-11-02 |
| Drug Identification Number | 02256711 | 02256711 |
| Brand name | RANITIDINE INJECTION USP | RANITIDINE INJECTION USP |
| Common or Proper name | RANITIDINE | RANITIDINE |
| Company Name | SANDOZ CANADA INCORPORATED | SANDOZ CANADA INCORPORATED |
| Ingredients | RANITIDINE | RANITIDINE |
| Strength(s) | 50MG | 50MG |
| Dosage form(s) | SOLUTION | SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 1 VIAL 50ML | 1 VIAL 50ML |
| ATC code | A02BA | A02BA |
| ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
| Reason for discontinuation | Manufacturing issues | Manufacturing issues |
| Anticipated discontinuation date | ||
| Actual discontinuation date | 2020-11-02 | 2020-11-02 |
| Remaining supply date | 2020-11-02 | 2020-11-02 |
| Discontinuation status | Discontinued | To be discontinued |
| Discontinuation decision reversal | no | no |
| Tier 3 Status | No | No |
| Information on remaining supply | ||
| Company comments | PrFamotidine Omega 10mg/mL as a substitute for PrRanitidine Injection USP 25 mg/mL | PrFamotidine Omega 10mg/mL as a substitute for PrRanitidine Injection USP 25 mg/mL |
| Health Canada comments |